SOD3: A Potential Drug Target and Biomarker for Cancer and Other Diseases

Target Name: SOD3

NCBI ID: G6649

SOD3

SOD3: A Potential Drug Target and Biomarker for Cancer and Other Diseases

SOD3 (SODE_HUMAN) is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker for several diseases. SOD3 is a key regulator of the cell cycle and has been shown to play a role in a variety of cellular processes, including cell growth, apoptosis, and inflammation.

One of the key features of SOD3 is its ability to interact with and regulate the activity of several different proteins, including tyrosine kinases. Tyrosine kinases are a family of enzymes that play a critical role in the signaling process that regulates cell growth and survival. SOD3 has been shown to regulate the activity of several tyrosine kinases, including TKL1 and TKL3, which are known to play a role in the development and progression of cancer.

In addition to its role in cell signaling, SOD3 has also been shown to have several potential drug targets. One of the most promising targets is the protein p21, which is a key regulator of the cell cycle and has been shown to play a role in the development of cancer. SOD3 has been shown to regulate the activity of p21 and has been shown to inhibit its activity in a variety of cellular contexts. This suggests that SOD3 may be an effective drug target for cancer therapies.

Another potential drug target for SOD3 is the protein p53, which is a well-known regulator of DNA repair and has been shown to play a critical role in the regulation of cellular processes. SOD3 has been shown to regulate the activity of p53 and has been shown to enhance its activity in the absence of SOD3. This suggests that SOD3 may be an effective drug target for diseases that are characterized by inflammation or DNA damage, such as cancer or neurodegenerative diseases.

In addition to its potential drug targets, SOD3 has also been shown to have several potential biomarkers. One of the most promising biomarkers is the protein SOD3, which has been shown to be expressed in a variety of human tissues and may be a useful marker for tracking disease progression in a variety of conditions. In addition, SOD3 has been shown to be expressed in several types of cancer, including breast cancer and lung cancer, which suggests that it may be an effective biomarker for these types of diseases.

Overall, SOD3 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in cellular processes and to develop effective therapies based on its properties.

Protein Name: Superoxide Dismutase 3

Functions: Protect the extracellular space from toxic effect of reactive oxygen intermediates by converting superoxide radicals into hydrogen peroxide and oxygen

The "SOD3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SOD3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets